These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12604517)

  • 1. New anti-human immunodeficiency virus type 1 6-aminoquinolones: mechanism of action.
    Parolin C; Gatto B; Del Vecchio C; Pecere T; Tramontano E; Cecchetti V; Fravolini A; Masiero S; Palumbo M; Palù G
    Antimicrob Agents Chemother; 2003 Mar; 47(3):889-96. PubMed ID: 12604517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Aminoquinolones as new potential anti-HIV agents.
    Cecchetti V; Parolin C; Moro S; Pecere T; Filipponi E; Calistri A; Tabarrini O; Gatto B; Palumbo M; Fravolini A; Palu' G
    J Med Chem; 2000 Oct; 43(20):3799-802. PubMed ID: 11020296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure modifications of 6-aminoquinolones with potent anti-HIV activity.
    Tabarrini O; Stevens M; Cecchetti V; Sabatini S; Dell'Uomo M; Manfroni G; Palumbo M; Pannecouque C; De Clercq E; Fravolini A
    J Med Chem; 2004 Oct; 47(22):5567-78. PubMed ID: 15481992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic analysis of the sensitivity of HIV-1 to inhibitors of the reverse transcriptase, protease, and integrase using a self-inactivating virus vector system.
    Jármy G; Heinkelein M; Weissbrich B; Jassoy C; Rethwilm A
    J Med Virol; 2001 Jul; 64(3):223-31. PubMed ID: 11424108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase.
    Wang Z; Vince R
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1293-6. PubMed ID: 18226894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Morita-Baylis-Hillman reaction in the synthesis of 3-[(N-cycloalkylbenzamido)methyl]-2-quinolones as potential HIV-1 integrase inhibitors.
    Sekgota KC; Majumder S; Isaacs M; Mnkandhla D; Hoppe HC; Khanye SD; Kriel FH; Coates J; Kaye PT
    Bioorg Chem; 2017 Dec; 75():310-316. PubMed ID: 29080495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase.
    Au TK; Collins RA; Lam TL; Ng TB; Fong WP; Wan DC
    FEBS Lett; 2000 Apr; 471(2-3):169-72. PubMed ID: 10767416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P; Prasad VR
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative.
    Richter S; Parolin C; Gatto B; Del Vecchio C; Brocca-Cofano E; Fravolini A; Palù G; Palumbo M
    Antimicrob Agents Chemother; 2004 May; 48(5):1895-9. PubMed ID: 15105155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
    Okamoto M; Okamoto T; Baba M
    Antimicrob Agents Chemother; 1999 Mar; 43(3):492-7. PubMed ID: 10049256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions.
    Svarovskaia ES; Barr R; Zhang X; Pais GC; Marchand C; Pommier Y; Burke TR; Pathak VK
    J Virol; 2004 Apr; 78(7):3210-22. PubMed ID: 15016842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase.
    Jones GS; Yu F; Zeynalzadegan A; Hesselgesser J; Chen X; Chen J; Jin H; Kim CU; Wright M; Geleziunas R; Tsiang M
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1194-203. PubMed ID: 19104010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 3-hydroxy-3-phenylpropanoate ester–AZT conjugates as potential dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors.
    Manyeruke MH; Olomola TO; Majumder S; Abrahams S; Isaacs M; Mautsa N; Mosebi S; Mnkandhla D; Hewer R; Hoppe HC; Klein R; Kaye PT
    Bioorg Med Chem; 2015 Dec; 23(24):7521-8. PubMed ID: 26775541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation.
    Zhang X; Huang SZ; Gu WG; Yang LM; Chen H; Zheng CB; Zhao YX; Wan DC; Zheng YT
    Chin J Nat Med; 2014 Mar; 12(3):186-93. PubMed ID: 24702804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.
    Daelemans D; Esté JA; Witvrouw M; Pannecouque C; Jonckheere H; Aquaro S; Perno CF; De Clercq E; Vandamme AM
    Mol Pharmacol; 1997 Dec; 52(6):1157-63. PubMed ID: 9396786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.
    Sato M; Motomura T; Aramaki H; Matsuda T; Yamashita M; Ito Y; Kawakami H; Matsuzaki Y; Watanabe W; Yamataka K; Ikeda S; Kodama E; Matsuoka M; Shinkai H
    J Med Chem; 2006 Mar; 49(5):1506-8. PubMed ID: 16509568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
    Gu SX; Xue P; Ju XL; Zhu YY
    Bioorg Med Chem; 2016 Nov; 24(21):5007-5016. PubMed ID: 27658796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.